Repligen Corp (NASDAQ:RGEN)

During the Trading Day
40.04 -1.17 / -2.84%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
40.04 0.00 / 0.00%
 
Volume: 277.00
No recent news for Repligen Corp.

Today’s Trading

Previous close41.21
Today’s open41.24
Day’s range39.96 - 41.64
Volume218,334
Average volume (3 months)394,277
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+32.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio196.1
Price/Sales10.36
Price/Book12.11

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.01-0.03%
MACKMerrimack Pharmaceut...-0.12-0.99%
ZSPHZS Pharma Inc+0.84+1.49%
TXMDTherapeuticsMD Inc+0.06+0.73%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
Tony J. Hunt
Chief Financial Officer
Jon K. Snodgres
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers